Private · Company · Aksjeselskap
Agiana Pharmaceuticals AS
927 648 946 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
↳ Brreg · companies
MoneyNOK
Revenue
kr 2.88M
Operating result
−kr 15.5M
Net result
−kr 15.2M
Total assets
kr 8.03M
Equity
kr 3.25M
FY2025 kr 2.88M vs FY2024 kr 535k · +439% revenue
Regnskapsregisteret · company_financials · FY2025 (company)
Group financialsNOK
- Revenue
- Net profit
| FY24 | FY25 | |
|---|---|---|
| Revenue | 535k | 2.88M |
| Net profit | -4.5M | -15.2M |
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY24FY25TREND
Revenue1M3M
Operating result-5M-15M
Net result-5M-15M
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITOpted out of audit (fravalg) on 3 Sep 2021.
BALANCEEquity kr 3.25M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose